A detailed history of Gamma Investing LLC transactions in Morpho Sys Ag stock. As of the latest transaction made, Gamma Investing LLC holds 4,092 shares of MOR stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,092
Previous 2,874 42.38%
Holding current value
$0
Previous $52.3 Million 48.32%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$0.0 - $18.96 $0 - $23,093
1,218 Added 42.38%
4,092 $77.6 Million
Q2 2024

Jul 02, 2024

BUY
$17.36 - $19.34 $16,162 - $18,005
931 Added 47.92%
2,874 $52.3 Million
Q1 2024

Apr 05, 2024

BUY
$8.6 - $18.18 $3,259 - $6,890
379 Added 24.23%
1,943 $35.2 Million
Q4 2023

Feb 01, 2024

BUY
$4.55 - $9.9 $7,116 - $15,483
1,564 New
1,564 $16.4 Million

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.